Alerts will be sent to your verified email
Verify Email
KOPRAN
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Kopran Limited is a pharmaceutical company that manufactures Active Pharmaceutical Ingredients and Finished Dosage Forms, with a wide range of products for international markets. It also offers specialty products and operates subsidiaries in research and life sciences.
Kopran major competitors are Shree Ganesh Remed., NGL Fine-Chem, Nectar Lifesciences, Hester Biosciences, Themis Medicare, SMS Lifesciences, Everest Organics.
Market Cap of Kopran is ₹932 Crs.
While the median market cap of its peers are ₹712 Crs.
Kopran seems to be less financially stable compared to its competitors.
Altman Z score of Kopran is 4.46 and is ranked 4 out of its 8 competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | Dec | |||||||||||||||||
| Investor Presentation | Mar Jun Sep Dec | Sep Dec | Mar May | Mar Sep | Sep Dec | |||||||||||||
| Conference Call | Mar Jun Sep Dec | Sep Dec | ||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
